 | • レポートコード：MRC23Q38154 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、116ページ • 納品方法：Eメール（2-3日） • 産業分類：医薬品 |
| Single User | ￥429,200 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥858,400 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界のペメトレキセド二ナトリウム凍結乾燥粉末市場について調査・分析し、世界のペメトレキセド二ナトリウム凍結乾燥粉末市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（100mg/個、500mg/個）、用途別セグメント分析（病院、クリニック、その他）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、Lilly、Amneal Pharmaceuticals、APOTEX、Fresenius Kabi、Sandoz、Baxter、Biocon、Waverley Pharma、Accord Healthcare、Pfizer (Hospira)、Dr. Reddy's Laboratories、Nang Kuang Pharmaceutical、Eugia Pharma、Zydus Lifesciences、Jiangsu Hansoh Pharmaceutical、Qilu Pharmaceutical、Sichuan Huiyu Pharmaceutical、Kelun Pharmaceutical、Yangtze River Pharmaceutical Group、Jiangsu Aosaikang Pharmaceutical、Zhendong Group、Lianyungang Jaripharm Pharmaceutical、Jiangsu Simcere Pharmaceutical、Suzhou Erye Pharmaceutical、Shanghai Chemo Wanbang Biopharma、Hainan Jinrui Pharmaceutical、Dezhou Deyao Pharmaceutical、Nanjing Pharmaceutical Factory、Beijing Xiehe Pharmaceutical、Suzhou Thery Pharmaceuticalなどが含まれています。世界のペメトレキセド二ナトリウム凍結乾燥粉末市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、ペメトレキセド二ナトリウム凍結乾燥粉末市場規模を推定する際に考慮しました。本レポートは、ペメトレキセド二ナトリウム凍結乾燥粉末の世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、ペメトレキセド二ナトリウム凍結乾燥粉末に関するビジネス上の意思決定に役立てることを目的としています。 ・ペメトレキセド二ナトリウム凍結乾燥粉末市場の概要 - 製品の定義 - ペメトレキセド二ナトリウム凍結乾燥粉末のタイプ別セグメント - 世界のペメトレキセド二ナトリウム凍結乾燥粉末市場規模：タイプ別分析（100mg/個、500mg/個） - ペメトレキセド二ナトリウム凍結乾燥粉末の用途別セグメント - 世界のペメトレキセド二ナトリウム凍結乾燥粉末市場規模：用途別分析（病院、クリニック、その他） - 世界のペメトレキセド二ナトリウム凍結乾燥粉末市場規模予測（2018年-2029年） - ペメトレキセド二ナトリウム凍結乾燥粉末の平均価格推移（2018年-2029年） - 前提条件と制限事項 ・メーカー別競争状況 - メーカー別市場シェア - 世界の主要メーカー、業界ランキング分析 - メーカー別平均価格 - ペメトレキセド二ナトリウム凍結乾燥粉末市場の競争状況およびトレンド ・ペメトレキセド二ナトリウム凍結乾燥粉末の地域別市場規模 - 北米のペメトレキセド二ナトリウム凍結乾燥粉末市場規模（2018年-2029年） - アメリカのペメトレキセド二ナトリウム凍結乾燥粉末市場規模（2018年-2029年） - ヨーロッパのペメトレキセド二ナトリウム凍結乾燥粉末市場規模（2018年-2029年） - アジア太平洋のペメトレキセド二ナトリウム凍結乾燥粉末市場規模（2018年-2029年） - 中国のペメトレキセド二ナトリウム凍結乾燥粉末市場規模（2018年-2029年） - 日本のペメトレキセド二ナトリウム凍結乾燥粉末市場規模（2018年-2029年） - 韓国のペメトレキセド二ナトリウム凍結乾燥粉末市場規模（2018年-2029年） - インドのペメトレキセド二ナトリウム凍結乾燥粉末市場規模（2018年-2029年） - オーストラリアのペメトレキセド二ナトリウム凍結乾燥粉末市場規模（2018年-2029年） - 中南米のペメトレキセド二ナトリウム凍結乾燥粉末市場規模（2018年-2029年） - 中東・アフリカのペメトレキセド二ナトリウム凍結乾燥粉末市場規模（2018年-2029年） ・タイプ別セグメント：100mg/個、500mg/個 - 世界のペメトレキセド二ナトリウム凍結乾燥粉末のタイプ別販売量（2018年-2023年） - 世界のペメトレキセド二ナトリウム凍結乾燥粉末のタイプ別売上（2018年-2023年） - 世界のペメトレキセド二ナトリウム凍結乾燥粉末のタイプ別価格 ・用途別セグメント：病院、クリニック、その他 - 世界のペメトレキセド二ナトリウム凍結乾燥粉末の用途別販売量（2018年-2023年） - 世界のペメトレキセド二ナトリウム凍結乾燥粉末の用途別売上（2018年-2023年） - 世界のペメトレキセド二ナトリウム凍結乾燥粉末の用途別価格 ・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向 Lilly、Amneal Pharmaceuticals、APOTEX、Fresenius Kabi、Sandoz、Baxter、Biocon、Waverley Pharma、Accord Healthcare、Pfizer (Hospira)、Dr. Reddy's Laboratories、Nang Kuang Pharmaceutical、Eugia Pharma、Zydus Lifesciences、Jiangsu Hansoh Pharmaceutical、Qilu Pharmaceutical、Sichuan Huiyu Pharmaceutical、Kelun Pharmaceutical、Yangtze River Pharmaceutical Group、Jiangsu Aosaikang Pharmaceutical、Zhendong Group、Lianyungang Jaripharm Pharmaceutical、Jiangsu Simcere Pharmaceutical、Suzhou Erye Pharmaceutical、Shanghai Chemo Wanbang Biopharma、Hainan Jinrui Pharmaceutical、Dezhou Deyao Pharmaceutical、Nanjing Pharmaceutical Factory、Beijing Xiehe Pharmaceutical、Suzhou Thery Pharmaceutical ・産業チェーンと販売チャネルの分析 - ペメトレキセド二ナトリウム凍結乾燥粉末産業チェーン分析 - ペメトレキセド二ナトリウム凍結乾燥粉末の主要原材料 - ペメトレキセド二ナトリウム凍結乾燥粉末の販売チャネル - ペメトレキセド二ナトリウム凍結乾燥粉末のディストリビューター - ペメトレキセド二ナトリウム凍結乾燥粉末の主要顧客 ・ペメトレキセド二ナトリウム凍結乾燥粉末市場ダイナミクス - ペメトレキセド二ナトリウム凍結乾燥粉末の業界動向 - ペメトレキセド二ナトリウム凍結乾燥粉末市場の成長ドライバ、課題、阻害要因 ・調査成果および結論 ・調査方法とデータソース |
Highlights
The global Pemetrexed Disodium Lyophilized Powder market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Pemetrexed Disodium Lyophilized Powder is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Pemetrexed Disodium Lyophilized Powder is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Pemetrexed Disodium Lyophilized Powder include Lilly, Amneal Pharmaceuticals, APOTEX, Fresenius Kabi, Sandoz, Baxter, Biocon, Waverley Pharma and Accord Healthcare, etc. in 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Pemetrexed Disodium Lyophilized Powder, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pemetrexed Disodium Lyophilized Powder.
The Pemetrexed Disodium Lyophilized Powder market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Pemetrexed Disodium Lyophilized Powder market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pemetrexed Disodium Lyophilized Powder manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Lilly
Amneal Pharmaceuticals
APOTEX
Fresenius Kabi
Sandoz
Baxter
Biocon
Waverley Pharma
Accord Healthcare
Pfizer (Hospira)
Dr. Reddy’s Laboratories
Nang Kuang Pharmaceutical
Eugia Pharma
Zydus Lifesciences
Jiangsu Hansoh Pharmaceutical
Qilu Pharmaceutical
Sichuan Huiyu Pharmaceutical
Kelun Pharmaceutical
Yangtze River Pharmaceutical Group
Jiangsu Aosaikang Pharmaceutical
Zhendong Group
Lianyungang Jaripharm Pharmaceutical
Jiangsu Simcere Pharmaceutical
Suzhou Erye Pharmaceutical
Shanghai Chemo Wanbang Biopharma
Hainan Jinrui Pharmaceutical
Dezhou Deyao Pharmaceutical
Nanjing Pharmaceutical Factory
Beijing Xiehe Pharmaceutical
Suzhou Thery Pharmaceutical
Segment by Type
100mg/Pcs
500mg/Pcs
Segment by Application
Hospitals
Clinics
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Pemetrexed Disodium Lyophilized Powder manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Pemetrexed Disodium Lyophilized Powder in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Pemetrexed Disodium Lyophilized Powder Market Overview
1.1 Product Overview and Scope of Pemetrexed Disodium Lyophilized Powder
1.2 Pemetrexed Disodium Lyophilized Powder Segment by Type
1.2.1 Global Pemetrexed Disodium Lyophilized Powder Market Value Comparison by Type (2023-2029)
1.2.2 100mg/Pcs
1.2.3 500mg/Pcs
1.3 Pemetrexed Disodium Lyophilized Powder Segment by Application
1.3.1 Global Pemetrexed Disodium Lyophilized Powder Market Value by Application: (2023-2029)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Pemetrexed Disodium Lyophilized Powder Market Size Estimates and Forecasts
1.4.1 Global Pemetrexed Disodium Lyophilized Powder Revenue 2018-2029
1.4.2 Global Pemetrexed Disodium Lyophilized Powder Sales 2018-2029
1.4.3 Global Pemetrexed Disodium Lyophilized Powder Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Pemetrexed Disodium Lyophilized Powder Market Competition by Manufacturers
2.1 Global Pemetrexed Disodium Lyophilized Powder Sales Market Share by Manufacturers (2018-2023)
2.2 Global Pemetrexed Disodium Lyophilized Powder Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Pemetrexed Disodium Lyophilized Powder Average Price by Manufacturers (2018-2023)
2.4 Global Pemetrexed Disodium Lyophilized Powder Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Pemetrexed Disodium Lyophilized Powder, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Pemetrexed Disodium Lyophilized Powder, Product Type & Application
2.7 Pemetrexed Disodium Lyophilized Powder Market Competitive Situation and Trends
2.7.1 Pemetrexed Disodium Lyophilized Powder Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Pemetrexed Disodium Lyophilized Powder Players Market Share by Revenue
2.7.3 Global Pemetrexed Disodium Lyophilized Powder Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Pemetrexed Disodium Lyophilized Powder Retrospective Market Scenario by Region
3.1 Global Pemetrexed Disodium Lyophilized Powder Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Pemetrexed Disodium Lyophilized Powder Global Pemetrexed Disodium Lyophilized Powder Sales by Region: 2018-2029
3.2.1 Global Pemetrexed Disodium Lyophilized Powder Sales by Region: 2018-2023
3.2.2 Global Pemetrexed Disodium Lyophilized Powder Sales by Region: 2024-2029
3.3 Global Pemetrexed Disodium Lyophilized Powder Global Pemetrexed Disodium Lyophilized Powder Revenue by Region: 2018-2029
3.3.1 Global Pemetrexed Disodium Lyophilized Powder Revenue by Region: 2018-2023
3.3.2 Global Pemetrexed Disodium Lyophilized Powder Revenue by Region: 2024-2029
3.4 North America Pemetrexed Disodium Lyophilized Powder Market Facts & Figures by Country
3.4.1 North America Pemetrexed Disodium Lyophilized Powder Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Pemetrexed Disodium Lyophilized Powder Sales by Country (2018-2029)
3.4.3 North America Pemetrexed Disodium Lyophilized Powder Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Pemetrexed Disodium Lyophilized Powder Market Facts & Figures by Country
3.5.1 Europe Pemetrexed Disodium Lyophilized Powder Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Pemetrexed Disodium Lyophilized Powder Sales by Country (2018-2029)
3.5.3 Europe Pemetrexed Disodium Lyophilized Powder Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pemetrexed Disodium Lyophilized Powder Market Facts & Figures by Country
3.6.1 Asia Pacific Pemetrexed Disodium Lyophilized Powder Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Pemetrexed Disodium Lyophilized Powder Sales by Country (2018-2029)
3.6.3 Asia Pacific Pemetrexed Disodium Lyophilized Powder Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Pemetrexed Disodium Lyophilized Powder Market Facts & Figures by Country
3.7.1 Latin America Pemetrexed Disodium Lyophilized Powder Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Pemetrexed Disodium Lyophilized Powder Sales by Country (2018-2029)
3.7.3 Latin America Pemetrexed Disodium Lyophilized Powder Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Pemetrexed Disodium Lyophilized Powder Market Facts & Figures by Country
3.8.1 Middle East and Africa Pemetrexed Disodium Lyophilized Powder Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Pemetrexed Disodium Lyophilized Powder Sales by Country (2018-2029)
3.8.3 Middle East and Africa Pemetrexed Disodium Lyophilized Powder Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Pemetrexed Disodium Lyophilized Powder Sales by Type (2018-2029)
4.1.1 Global Pemetrexed Disodium Lyophilized Powder Sales by Type (2018-2023)
4.1.2 Global Pemetrexed Disodium Lyophilized Powder Sales by Type (2024-2029)
4.1.3 Global Pemetrexed Disodium Lyophilized Powder Sales Market Share by Type (2018-2029)
4.2 Global Pemetrexed Disodium Lyophilized Powder Revenue by Type (2018-2029)
4.2.1 Global Pemetrexed Disodium Lyophilized Powder Revenue by Type (2018-2023)
4.2.2 Global Pemetrexed Disodium Lyophilized Powder Revenue by Type (2024-2029)
4.2.3 Global Pemetrexed Disodium Lyophilized Powder Revenue Market Share by Type (2018-2029)
4.3 Global Pemetrexed Disodium Lyophilized Powder Price by Type (2018-2029)
5 Segment by Application
5.1 Global Pemetrexed Disodium Lyophilized Powder Sales by Application (2018-2029)
5.1.1 Global Pemetrexed Disodium Lyophilized Powder Sales by Application (2018-2023)
5.1.2 Global Pemetrexed Disodium Lyophilized Powder Sales by Application (2024-2029)
5.1.3 Global Pemetrexed Disodium Lyophilized Powder Sales Market Share by Application (2018-2029)
5.2 Global Pemetrexed Disodium Lyophilized Powder Revenue by Application (2018-2029)
5.2.1 Global Pemetrexed Disodium Lyophilized Powder Revenue by Application (2018-2023)
5.2.2 Global Pemetrexed Disodium Lyophilized Powder Revenue by Application (2024-2029)
5.2.3 Global Pemetrexed Disodium Lyophilized Powder Revenue Market Share by Application (2018-2029)
5.3 Global Pemetrexed Disodium Lyophilized Powder Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Lilly
6.1.1 Lilly Corporation Information
6.1.2 Lilly Description and Business Overview
6.1.3 Lilly Pemetrexed Disodium Lyophilized Powder Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Lilly Pemetrexed Disodium Lyophilized Powder Product Portfolio
6.1.5 Lilly Recent Developments/Updates
6.2 Amneal Pharmaceuticals
6.2.1 Amneal Pharmaceuticals Corporation Information
6.2.2 Amneal Pharmaceuticals Description and Business Overview
6.2.3 Amneal Pharmaceuticals Pemetrexed Disodium Lyophilized Powder Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Amneal Pharmaceuticals Pemetrexed Disodium Lyophilized Powder Product Portfolio
6.2.5 Amneal Pharmaceuticals Recent Developments/Updates
6.3 APOTEX
6.3.1 APOTEX Corporation Information
6.3.2 APOTEX Description and Business Overview
6.3.3 APOTEX Pemetrexed Disodium Lyophilized Powder Sales, Revenue and Gross Margin (2018-2023)
6.3.4 APOTEX Pemetrexed Disodium Lyophilized Powder Product Portfolio
6.3.5 APOTEX Recent Developments/Updates
6.4 Fresenius Kabi
6.4.1 Fresenius Kabi Corporation Information
6.4.2 Fresenius Kabi Description and Business Overview
6.4.3 Fresenius Kabi Pemetrexed Disodium Lyophilized Powder Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Fresenius Kabi Pemetrexed Disodium Lyophilized Powder Product Portfolio
6.4.5 Fresenius Kabi Recent Developments/Updates
6.5 Sandoz
6.5.1 Sandoz Corporation Information
6.5.2 Sandoz Description and Business Overview
6.5.3 Sandoz Pemetrexed Disodium Lyophilized Powder Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Sandoz Pemetrexed Disodium Lyophilized Powder Product Portfolio
6.5.5 Sandoz Recent Developments/Updates
6.6 Baxter
6.6.1 Baxter Corporation Information
6.6.2 Baxter Description and Business Overview
6.6.3 Baxter Pemetrexed Disodium Lyophilized Powder Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Baxter Pemetrexed Disodium Lyophilized Powder Product Portfolio
6.6.5 Baxter Recent Developments/Updates
6.7 Biocon
6.6.1 Biocon Corporation Information
6.6.2 Biocon Description and Business Overview
6.6.3 Biocon Pemetrexed Disodium Lyophilized Powder Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Biocon Pemetrexed Disodium Lyophilized Powder Product Portfolio
6.7.5 Biocon Recent Developments/Updates
6.8 Waverley Pharma
6.8.1 Waverley Pharma Corporation Information
6.8.2 Waverley Pharma Description and Business Overview
6.8.3 Waverley Pharma Pemetrexed Disodium Lyophilized Powder Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Waverley Pharma Pemetrexed Disodium Lyophilized Powder Product Portfolio
6.8.5 Waverley Pharma Recent Developments/Updates
6.9 Accord Healthcare
6.9.1 Accord Healthcare Corporation Information
6.9.2 Accord Healthcare Description and Business Overview
6.9.3 Accord Healthcare Pemetrexed Disodium Lyophilized Powder Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Accord Healthcare Pemetrexed Disodium Lyophilized Powder Product Portfolio
6.9.5 Accord Healthcare Recent Developments/Updates
6.10 Pfizer (Hospira)
6.10.1 Pfizer (Hospira) Corporation Information
6.10.2 Pfizer (Hospira) Description and Business Overview
6.10.3 Pfizer (Hospira) Pemetrexed Disodium Lyophilized Powder Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Pfizer (Hospira) Pemetrexed Disodium Lyophilized Powder Product Portfolio
6.10.5 Pfizer (Hospira) Recent Developments/Updates
6.11 Dr. Reddy’s Laboratories
6.11.1 Dr. Reddy’s Laboratories Corporation Information
6.11.2 Dr. Reddy’s Laboratories Pemetrexed Disodium Lyophilized Powder Description and Business Overview
6.11.3 Dr. Reddy’s Laboratories Pemetrexed Disodium Lyophilized Powder Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Dr. Reddy’s Laboratories Pemetrexed Disodium Lyophilized Powder Product Portfolio
6.11.5 Dr. Reddy’s Laboratories Recent Developments/Updates
6.12 Nang Kuang Pharmaceutical
6.12.1 Nang Kuang Pharmaceutical Corporation Information
6.12.2 Nang Kuang Pharmaceutical Pemetrexed Disodium Lyophilized Powder Description and Business Overview
6.12.3 Nang Kuang Pharmaceutical Pemetrexed Disodium Lyophilized Powder Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Nang Kuang Pharmaceutical Pemetrexed Disodium Lyophilized Powder Product Portfolio
6.12.5 Nang Kuang Pharmaceutical Recent Developments/Updates
6.13 Eugia Pharma
6.13.1 Eugia Pharma Corporation Information
6.13.2 Eugia Pharma Pemetrexed Disodium Lyophilized Powder Description and Business Overview
6.13.3 Eugia Pharma Pemetrexed Disodium Lyophilized Powder Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Eugia Pharma Pemetrexed Disodium Lyophilized Powder Product Portfolio
6.13.5 Eugia Pharma Recent Developments/Updates
6.14 Zydus Lifesciences
6.14.1 Zydus Lifesciences Corporation Information
6.14.2 Zydus Lifesciences Pemetrexed Disodium Lyophilized Powder Description and Business Overview
6.14.3 Zydus Lifesciences Pemetrexed Disodium Lyophilized Powder Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Zydus Lifesciences Pemetrexed Disodium Lyophilized Powder Product Portfolio
6.14.5 Zydus Lifesciences Recent Developments/Updates
6.15 Jiangsu Hansoh Pharmaceutical
6.15.1 Jiangsu Hansoh Pharmaceutical Corporation Information
6.15.2 Jiangsu Hansoh Pharmaceutical Pemetrexed Disodium Lyophilized Powder Description and Business Overview
6.15.3 Jiangsu Hansoh Pharmaceutical Pemetrexed Disodium Lyophilized Powder Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Jiangsu Hansoh Pharmaceutical Pemetrexed Disodium Lyophilized Powder Product Portfolio
6.15.5 Jiangsu Hansoh Pharmaceutical Recent Developments/Updates
6.16 Qilu Pharmaceutical
6.16.1 Qilu Pharmaceutical Corporation Information
6.16.2 Qilu Pharmaceutical Pemetrexed Disodium Lyophilized Powder Description and Business Overview
6.16.3 Qilu Pharmaceutical Pemetrexed Disodium Lyophilized Powder Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Qilu Pharmaceutical Pemetrexed Disodium Lyophilized Powder Product Portfolio
6.16.5 Qilu Pharmaceutical Recent Developments/Updates
6.17 Sichuan Huiyu Pharmaceutical
6.17.1 Sichuan Huiyu Pharmaceutical Corporation Information
6.17.2 Sichuan Huiyu Pharmaceutical Pemetrexed Disodium Lyophilized Powder Description and Business Overview
6.17.3 Sichuan Huiyu Pharmaceutical Pemetrexed Disodium Lyophilized Powder Sales, Revenue and Gross Margin (2018-2023)
6.17.4 Sichuan Huiyu Pharmaceutical Pemetrexed Disodium Lyophilized Powder Product Portfolio
6.17.5 Sichuan Huiyu Pharmaceutical Recent Developments/Updates
6.18 Kelun Pharmaceutical
6.18.1 Kelun Pharmaceutical Corporation Information
6.18.2 Kelun Pharmaceutical Pemetrexed Disodium Lyophilized Powder Description and Business Overview
6.18.3 Kelun Pharmaceutical Pemetrexed Disodium Lyophilized Powder Sales, Revenue and Gross Margin (2018-2023)
6.18.4 Kelun Pharmaceutical Pemetrexed Disodium Lyophilized Powder Product Portfolio
6.18.5 Kelun Pharmaceutical Recent Developments/Updates
6.19 Yangtze River Pharmaceutical Group
6.19.1 Yangtze River Pharmaceutical Group Corporation Information
6.19.2 Yangtze River Pharmaceutical Group Pemetrexed Disodium Lyophilized Powder Description and Business Overview
6.19.3 Yangtze River Pharmaceutical Group Pemetrexed Disodium Lyophilized Powder Sales, Revenue and Gross Margin (2018-2023)
6.19.4 Yangtze River Pharmaceutical Group Pemetrexed Disodium Lyophilized Powder Product Portfolio
6.19.5 Yangtze River Pharmaceutical Group Recent Developments/Updates
6.20 Jiangsu Aosaikang Pharmaceutical
6.20.1 Jiangsu Aosaikang Pharmaceutical Corporation Information
6.20.2 Jiangsu Aosaikang Pharmaceutical Pemetrexed Disodium Lyophilized Powder Description and Business Overview
6.20.3 Jiangsu Aosaikang Pharmaceutical Pemetrexed Disodium Lyophilized Powder Sales, Revenue and Gross Margin (2018-2023)
6.20.4 Jiangsu Aosaikang Pharmaceutical Pemetrexed Disodium Lyophilized Powder Product Portfolio
6.20.5 Jiangsu Aosaikang Pharmaceutical Recent Developments/Updates
6.21 Zhendong Group
6.21.1 Zhendong Group Corporation Information
6.21.2 Zhendong Group Pemetrexed Disodium Lyophilized Powder Description and Business Overview
6.21.3 Zhendong Group Pemetrexed Disodium Lyophilized Powder Sales, Revenue and Gross Margin (2018-2023)
6.21.4 Zhendong Group Pemetrexed Disodium Lyophilized Powder Product Portfolio
6.21.5 Zhendong Group Recent Developments/Updates
6.22 Lianyungang Jaripharm Pharmaceutical
6.22.1 Lianyungang Jaripharm Pharmaceutical Corporation Information
6.22.2 Lianyungang Jaripharm Pharmaceutical Pemetrexed Disodium Lyophilized Powder Description and Business Overview
6.22.3 Lianyungang Jaripharm Pharmaceutical Pemetrexed Disodium Lyophilized Powder Sales, Revenue and Gross Margin (2018-2023)
6.22.4 Lianyungang Jaripharm Pharmaceutical Pemetrexed Disodium Lyophilized Powder Product Portfolio
6.22.5 Lianyungang Jaripharm Pharmaceutical Recent Developments/Updates
6.23 Jiangsu Simcere Pharmaceutical
6.23.1 Jiangsu Simcere Pharmaceutical Corporation Information
6.23.2 Jiangsu Simcere Pharmaceutical Pemetrexed Disodium Lyophilized Powder Description and Business Overview
6.23.3 Jiangsu Simcere Pharmaceutical Pemetrexed Disodium Lyophilized Powder Sales, Revenue and Gross Margin (2018-2023)
6.23.4 Jiangsu Simcere Pharmaceutical Pemetrexed Disodium Lyophilized Powder Product Portfolio
6.23.5 Jiangsu Simcere Pharmaceutical Recent Developments/Updates
6.24 Suzhou Erye Pharmaceutical
6.24.1 Suzhou Erye Pharmaceutical Corporation Information
6.24.2 Suzhou Erye Pharmaceutical Pemetrexed Disodium Lyophilized Powder Description and Business Overview
6.24.3 Suzhou Erye Pharmaceutical Pemetrexed Disodium Lyophilized Powder Sales, Revenue and Gross Margin (2018-2023)
6.24.4 Suzhou Erye Pharmaceutical Pemetrexed Disodium Lyophilized Powder Product Portfolio
6.24.5 Suzhou Erye Pharmaceutical Recent Developments/Updates
6.25 Shanghai Chemo Wanbang Biopharma
6.25.1 Shanghai Chemo Wanbang Biopharma Corporation Information
6.25.2 Shanghai Chemo Wanbang Biopharma Pemetrexed Disodium Lyophilized Powder Description and Business Overview
6.25.3 Shanghai Chemo Wanbang Biopharma Pemetrexed Disodium Lyophilized Powder Sales, Revenue and Gross Margin (2018-2023)
6.25.4 Shanghai Chemo Wanbang Biopharma Pemetrexed Disodium Lyophilized Powder Product Portfolio
6.25.5 Shanghai Chemo Wanbang Biopharma Recent Developments/Updates
6.26 Hainan Jinrui Pharmaceutical
6.26.1 Hainan Jinrui Pharmaceutical Corporation Information
6.26.2 Hainan Jinrui Pharmaceutical Pemetrexed Disodium Lyophilized Powder Description and Business Overview
6.26.3 Hainan Jinrui Pharmaceutical Pemetrexed Disodium Lyophilized Powder Sales, Revenue and Gross Margin (2018-2023)
6.26.4 Hainan Jinrui Pharmaceutical Pemetrexed Disodium Lyophilized Powder Product Portfolio
6.26.5 Hainan Jinrui Pharmaceutical Recent Developments/Updates
6.27 Dezhou Deyao Pharmaceutical
6.27.1 Dezhou Deyao Pharmaceutical Corporation Information
6.27.2 Dezhou Deyao Pharmaceutical Pemetrexed Disodium Lyophilized Powder Description and Business Overview
6.27.3 Dezhou Deyao Pharmaceutical Pemetrexed Disodium Lyophilized Powder Sales, Revenue and Gross Margin (2018-2023)
6.27.4 Dezhou Deyao Pharmaceutical Pemetrexed Disodium Lyophilized Powder Product Portfolio
6.27.5 Dezhou Deyao Pharmaceutical Recent Developments/Updates
6.28 Nanjing Pharmaceutical Factory
6.28.1 Nanjing Pharmaceutical Factory Corporation Information
6.28.2 Nanjing Pharmaceutical Factory Pemetrexed Disodium Lyophilized Powder Description and Business Overview
6.28.3 Nanjing Pharmaceutical Factory Pemetrexed Disodium Lyophilized Powder Sales, Revenue and Gross Margin (2018-2023)
6.28.4 Nanjing Pharmaceutical Factory Pemetrexed Disodium Lyophilized Powder Product Portfolio
6.28.5 Nanjing Pharmaceutical Factory Recent Developments/Updates
6.29 Beijing Xiehe Pharmaceutical
6.29.1 Beijing Xiehe Pharmaceutical Corporation Information
6.29.2 Beijing Xiehe Pharmaceutical Pemetrexed Disodium Lyophilized Powder Description and Business Overview
6.29.3 Beijing Xiehe Pharmaceutical Pemetrexed Disodium Lyophilized Powder Sales, Revenue and Gross Margin (2018-2023)
6.29.4 Beijing Xiehe Pharmaceutical Pemetrexed Disodium Lyophilized Powder Product Portfolio
6.29.5 Beijing Xiehe Pharmaceutical Recent Developments/Updates
6.30 Suzhou Thery Pharmaceutical
6.30.1 Suzhou Thery Pharmaceutical Corporation Information
6.30.2 Suzhou Thery Pharmaceutical Pemetrexed Disodium Lyophilized Powder Description and Business Overview
6.30.3 Suzhou Thery Pharmaceutical Pemetrexed Disodium Lyophilized Powder Sales, Revenue and Gross Margin (2018-2023)
6.30.4 Suzhou Thery Pharmaceutical Pemetrexed Disodium Lyophilized Powder Product Portfolio
6.30.5 Suzhou Thery Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pemetrexed Disodium Lyophilized Powder Industry Chain Analysis
7.2 Pemetrexed Disodium Lyophilized Powder Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pemetrexed Disodium Lyophilized Powder Production Mode & Process
7.4 Pemetrexed Disodium Lyophilized Powder Sales and Marketing
7.4.1 Pemetrexed Disodium Lyophilized Powder Sales Channels
7.4.2 Pemetrexed Disodium Lyophilized Powder Distributors
7.5 Pemetrexed Disodium Lyophilized Powder Customers
8 Pemetrexed Disodium Lyophilized Powder Market Dynamics
8.1 Pemetrexed Disodium Lyophilized Powder Industry Trends
8.2 Pemetrexed Disodium Lyophilized Powder Market Drivers
8.3 Pemetrexed Disodium Lyophilized Powder Market Challenges
8.4 Pemetrexed Disodium Lyophilized Powder Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer